Enhanced Radiopaque Substance for Additive Manufacturing

Publication ID: 24-11857649_0001_PTD
Published: October 28, 2025
Category:Direct Improvements & Enhancements

Legal Citation

pr1or.art Inc., “Enhanced Radiopaque Substance for Additive Manufacturing,” Published Technical Disclosure No. 24-11857649_0001_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857649_0001_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,649.

Summary of the Inventive Concept

A curable radiopaque substance adapted for use in additive manufacturing processes, offering improved layer adhesion and enhanced material properties.

Background and Problem Solved

The original patent disclosed a curable radiopaque substance, but it had limitations in its application in additive manufacturing processes, specifically with regards to layer adhesion. This new inventive concept addresses these limitations by introducing adaptations that enable the substance to be used effectively in additive manufacturing.

Detailed Description of the Inventive Concept

The enhanced curable radiopaque substance comprises a polymerization monomer or a mixture of polymerization monomers, and one or more compounds selected from the group consisting of strontium compounds, zirconium compounds, lead compounds, barium compounds, bismuth compounds, and rare earth compounds. The substance is specifically adapted for use in additive manufacturing processes, featuring improved layer adhesion due to its modified composition. The substance can be used in various applications, including the production of materials with high density and Shore hardness, as well as in the fabrication of lenses and other optical components.

Novelty and Inventive Step

The new claims introduce the novel feature of adapting the curable radiopaque substance for use in additive manufacturing processes, which is not disclosed in the original patent. This adaptation, combined with the specific composition of the substance, provides an inventive step over the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include variations in the composition of the substance, such as using different types of polymerization monomers or radiopaque compounds. Additionally, the substance could be adapted for use in other manufacturing processes, such as injection molding or 3D printing.

Potential Commercial Applications and Market

The enhanced curable radiopaque substance has significant commercial potential in the additive manufacturing industry, particularly in the production of high-performance materials and optical components. The target market includes companies involved in the development of advanced materials and manufacturing technologies.

CPC Classifications

SectionClassGroup
A A61 A61K6/70
A A61 A61K6/847
A A61 A61K6/887
C C08 C08F220/12

Field of Art

Dental and medical materials engineering, specifically polymer chemistry and additive manufacturing technologies focused on radiopaque composite substances for medical and dental applications

Person of Ordinary Skill (PHOSITA) Profile

A materials scientist or chemical engineer with expertise in polymer chemistry, experience with radiation-curable compositions, knowledge of radiopaque additives, and familiarity with advanced manufacturing techniques like 3D printing

Obviousness Rationale

A person of ordinary skill would recognize that adapting the source patent's radiopaque substance composition for additive manufacturing represents a predictable variation within the known design space of polymer materials. The core chemical composition remains substantially similar, with the primary modification being process-specific optimization for layer-by-layer fabrication techniques. The PTD's claims represent routine engineering adaptations that would be obvious to a skilled practitioner seeking to apply the radiopaque substance in advanced manufacturing contexts.

Obvious Combinations & Variations

Source Patent Element
Polymerizable monomers including acrylic and methacrylic acid derivatives
PTD Variation
Specific adaptation of these monomers for additive manufacturing with improved layer adhesion
Obviousness Reasoning
Modifying monomer compositions for specific manufacturing processes is a standard design optimization technique known to those skilled in polymer engineering
Source Patent Element
Radiopaque compounds including strontium, zirconium, and bismuth compounds
PTD Variation
Tailoring radiopaque compound concentrations for enhanced material properties in 3D printing applications
Obviousness Reasoning
Adjusting additive concentrations to optimize material performance is a predictable variation within material science design principles
Source Patent Element
Free-radically curable monomers
PTD Variation
Using high-intensity UV radiation sources specifically for layer-by-layer polymerization
Obviousness Reasoning
Selecting appropriate radiation curing techniques for specific manufacturing processes represents a known and obvious engineering adaptation
Source Patent Element
Curable substance for producing materials
PTD Variation
Developing a system integrating digital modeling, printing device, and radiation source for additive manufacturing
Obviousness Reasoning
Combining known manufacturing technologies with established polymer compositions represents a routine technological integration
Source Patent Element
Base radiopaque substance composition
PTD Variation
Producing high-density materials with specific Shore hardness for optical and medical applications
Obviousness Reasoning
Targeting specific material properties through compositional modifications is a standard approach in materials engineering
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857649 and the disclosed variations, a person of ordinary skill in the art would find the claimed additive manufacturing adaptations of the radiopaque substance composition to be obvious and lacking inventive step. The PTD demonstrates that the claimed variations represent predictable extensions of the prior art, employing routine design optimization techniques within the established technological framework of radiation-curable polymer compositions.

Original Patent Information

Patent NumberUS 11,857,649
TitleCurable radiopaque substance
Assignee(s)Merz Dental GmbH